Oral ATP treatment in alternating hemiplegia of childhood: a case report and review

Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that usually manifests before 18 months of age and is characterized by recurrent, alternating episodes of hemiparesis with variable frequency and can last from a few minutes to several days. We present a case of AHC in a littl...

Full description

Saved in:
Bibliographic Details
Main Authors: Marco Carrozzi, Maria Elisa Morelli, Mario Cirino, Alessandra Maestro, Gilda Paternuosto, Giulia Benericetti, Giada Bennati, Maura Bin, Anna Flamigni, Federico Pigato, Natalia Maximova, Egidio Barbi, Davide Zanon
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1433217/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841556630478520320
author Marco Carrozzi
Maria Elisa Morelli
Mario Cirino
Alessandra Maestro
Gilda Paternuosto
Giulia Benericetti
Giada Bennati
Maura Bin
Anna Flamigni
Federico Pigato
Natalia Maximova
Egidio Barbi
Egidio Barbi
Davide Zanon
author_facet Marco Carrozzi
Maria Elisa Morelli
Mario Cirino
Alessandra Maestro
Gilda Paternuosto
Giulia Benericetti
Giada Bennati
Maura Bin
Anna Flamigni
Federico Pigato
Natalia Maximova
Egidio Barbi
Egidio Barbi
Davide Zanon
author_sort Marco Carrozzi
collection DOAJ
description Alternating hemiplegia of childhood (AHC) is a rare neurological disorder that usually manifests before 18 months of age and is characterized by recurrent, alternating episodes of hemiparesis with variable frequency and can last from a few minutes to several days. We present a case of AHC in a little girl carrying a sporadic mutation in the ATP1A3 gene (p.Glu815Lys) refractory to flunarizine and non-compliant to topiramate due to adverse effects treated with oral compound of adenosine-5′-triphosphate (ATP) capsules. Outcome was evaluated through the follow-up and side effects and safety were monitored regularly. Compounded drug showed effectiveness and safety. Indeed, during the four-year follow-up, with the dose of adenosine-5′-triphosphate gradually increasing up to 21 mg/kg, the patient showed a substantial benefit in controlling the frequency and duration of hemiplegic episodes and an improvement in neurological deterioration.
format Article
id doaj-art-363dfc03b7754a4ea79cd4e7f311de8c
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-363dfc03b7754a4ea79cd4e7f311de8c2025-01-07T06:51:41ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011110.3389/fmed.2024.14332171433217Oral ATP treatment in alternating hemiplegia of childhood: a case report and reviewMarco Carrozzi0Maria Elisa Morelli1Mario Cirino2Alessandra Maestro3Gilda Paternuosto4Giulia Benericetti5Giada Bennati6Maura Bin7Anna Flamigni8Federico Pigato9Natalia Maximova10Egidio Barbi11Egidio Barbi12Davide Zanon13Institute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyDepartment of Medicine, Surgery and Health Sciences, University of Trieste, Trieste, ItalyInstitute for Maternal and Child Health Burlo Garofolo (IRCCS), Trieste, ItalyAlternating hemiplegia of childhood (AHC) is a rare neurological disorder that usually manifests before 18 months of age and is characterized by recurrent, alternating episodes of hemiparesis with variable frequency and can last from a few minutes to several days. We present a case of AHC in a little girl carrying a sporadic mutation in the ATP1A3 gene (p.Glu815Lys) refractory to flunarizine and non-compliant to topiramate due to adverse effects treated with oral compound of adenosine-5′-triphosphate (ATP) capsules. Outcome was evaluated through the follow-up and side effects and safety were monitored regularly. Compounded drug showed effectiveness and safety. Indeed, during the four-year follow-up, with the dose of adenosine-5′-triphosphate gradually increasing up to 21 mg/kg, the patient showed a substantial benefit in controlling the frequency and duration of hemiplegic episodes and an improvement in neurological deterioration.https://www.frontiersin.org/articles/10.3389/fmed.2024.1433217/fulladenosine-5′-triphosphateATPalternating hemiplegia of childhoodrare diseasecompoundclinical galenic
spellingShingle Marco Carrozzi
Maria Elisa Morelli
Mario Cirino
Alessandra Maestro
Gilda Paternuosto
Giulia Benericetti
Giada Bennati
Maura Bin
Anna Flamigni
Federico Pigato
Natalia Maximova
Egidio Barbi
Egidio Barbi
Davide Zanon
Oral ATP treatment in alternating hemiplegia of childhood: a case report and review
Frontiers in Medicine
adenosine-5′-triphosphate
ATP
alternating hemiplegia of childhood
rare disease
compound
clinical galenic
title Oral ATP treatment in alternating hemiplegia of childhood: a case report and review
title_full Oral ATP treatment in alternating hemiplegia of childhood: a case report and review
title_fullStr Oral ATP treatment in alternating hemiplegia of childhood: a case report and review
title_full_unstemmed Oral ATP treatment in alternating hemiplegia of childhood: a case report and review
title_short Oral ATP treatment in alternating hemiplegia of childhood: a case report and review
title_sort oral atp treatment in alternating hemiplegia of childhood a case report and review
topic adenosine-5′-triphosphate
ATP
alternating hemiplegia of childhood
rare disease
compound
clinical galenic
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1433217/full
work_keys_str_mv AT marcocarrozzi oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT mariaelisamorelli oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT mariocirino oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT alessandramaestro oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT gildapaternuosto oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT giuliabenericetti oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT giadabennati oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT maurabin oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT annaflamigni oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT federicopigato oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT nataliamaximova oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT egidiobarbi oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT egidiobarbi oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview
AT davidezanon oralatptreatmentinalternatinghemiplegiaofchildhoodacasereportandreview